Sciatica - Nerve Care

Manufacturer
Newton Laboratories, Inc.
Effective date
2011-03-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:05:19

Label at a glance#

ProductSciatica - Nerve Care
Active ingredientAconitum Napellus, Ammonium Benzoate, Arsenic Trioxide, Benzoic Acid, Bryonia Alba Root, Causticum, Cinchona Officinalis Bark, Colchicum Autumnale Bulb, Pseudognaphalium Obtusifolium, Iris Versicolor Root, Potassium Iodide, Ledum Palustre Twig, Lithium Carbonate, Strychnos Nux-vomica Seed, Phytolacca Americana Root, Toxicodendron Pubescens Leaf, Ruta Graveolens Flowering Top, Sambucus Nigra Flowering Top, Strychnine, Hypericum Perforatum, Urtica Urens
Label structure10 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Sciatica - Nerve Care  Formulated for associated symptoms such as sharp or throbbing pain, inflammation, numbness and discomfort.

DOSAGE & ADMINISTRATION SECTION

Directions:  Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water.  Sensitive persons begin with 1 pellet and gradually increase to full dose.

OTC - ACTIVE INGREDIENT SECTION

Aconitum nap. 15x, Ammonium benzoicum 15x, Arsenicum alb. 15x, Benzoicum acidum 15x, Bryonia15x, Causticum 15x, Cinchona 15x, Colchicum 15x, Gnaphalium polycephalum 15x, Iris versicolor 15x, Kali iod. 15x, Ledum 15x, Lithium carb. 15x, Nux vom. 15x, Phytolacca 15x, Rhus toxicodendron 15x, Ruta 15x, Sambucus nig. 15x, Strychninum 15x, Hypericum 3x, Urtica ur. 3x.

OTC - PURPOSE SECTION

Formulated for associated symptoms such as sharp or throbbing pain, inflammation, numbness and discomfort.

INACTIVE INGREDIENT SECTION

Inactive Ingredients:  Gluten-free, non-GMO, beet-derived sucrose pellets.  

QUESTIONS SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions?  1.800.448.7256 

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. 

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package label
package label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b3053bb1-353b-4a0b-bca5-28fe7228957cProduct name220250124
63f39a63-5cd1-4016-bd86-2bbb0f6c3139Product name320240506
e5a77e9c-c528-733a-173d-914a234c024bProduct name520240506
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
8ce6e144-236f-b7be-f690-f06e0c8c6bd3Product name220170725
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
f09af6ee-c6dd-d0ce-77ad-93508bcdacedProduct name420161205

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55714-2297-02020-01-31C16284748780-19d75b9d0-84b8-f424-e053-dadaa90a57ceSciatica - Nerve Care
55714-2297-12020-01-31C16284748780-19d75b9d0-84b8-f424-e053-dadaa90a57ceSciatica - Nerve Care
55714-2297-22020-01-31C16284748780-19d75b9d0-84b8-f424-e053-dadaa90a57ceSciatica - Nerve Care

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55714-2297-0Sciatica - Nerve Care7.08 g in 1 BOTTLE, GLASSPELLET7.081
55714-2297-1Sciatica - Nerve Care28.35 g in 1 BOTTLE, GLASSPELLET28.351
55714-2297-2Sciatica - Nerve Care56.7 g in 1 BOTTLE, GLASSPELLET56.71

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55714-2297SCIATICA - NERVE CARE (ACONITUM NAP., AMMONIUM BENZOICUM, ARSENICUM ALB., BENZOICUM ACIDUM, BRYONIA, CAUSTICUM, CINCHONA, COLCHICUM, GNAPHALIUM POLYCEPHALUM, IRIS VERSICOLOR, KALI IOD., LEDUM, LITHIUM CARB., NUX VOM., PHYTOLACCA, RHUS TOXICODERON, RUTA, SAMBUCUS NIG., STRYCHNINUM, HYPERICUM, URTICA UR) PELLET [NEWTON LABORATORIES, INC.]1Legacy NDC, 3 package rows20131218_7d643143-7305-bf15-cdeb-d0a6dffc1ba5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Aconitum NapellusACTIVE INGREDIENTU0NQ8555JD1
Ammonium BenzoateACTIVE INGREDIENTAC80WD7GPF1
Arsenic TrioxideACTIVE INGREDIENTS7V92P67HO1
Benzoic AcidACTIVE INGREDIENT8SKN0B0MIM1
Bryonia Alba RootACTIVE INGREDIENTT7J046YI2B1
CausticumACTIVE INGREDIENTDD5FO1WKFU1
Cinchona Officinalis BarkACTIVE INGREDIENTS003A158SB1
Colchicum Autumnale BulbACTIVE INGREDIENT993QHL78E61
Hypericum PerforatumACTIVE INGREDIENTXK4IUX8MNB1
Iris Versicolor RootACTIVE INGREDIENTX43D4L3DQC1
Ledum Palustre TwigACTIVE INGREDIENT877L01IZ0P1
Lithium CarbonateACTIVE INGREDIENT2BMD2GNA4V1
Phytolacca Americana RootACTIVE INGREDIENT11E6VI8VEG1
Potassium IodideACTIVE INGREDIENT1C4QK22F9J1
Pseudognaphalium ObtusifoliumACTIVE INGREDIENT36XQ854NWW1
Ruta Graveolens Flowering TopACTIVE INGREDIENTN94C2U587S1
Sambucus Nigra Flowering TopACTIVE INGREDIENTCT03BSA18U1
StrychnineACTIVE INGREDIENTH9Y79VD43J1
Strychnos Nux-vomica SeedACTIVE INGREDIENT269XH139191
Toxicodendron Pubescens LeafACTIVE INGREDIENT6IO182RP7A1
Urtica UrensACTIVE INGREDIENTIHN2NQ5OF91
Aconitum NapellusACTIVE MOIETYU0NQ8555JD1
Ammonium BenzoateACTIVE MOIETYAC80WD7GPF1
Arsenic Cation (3+)ACTIVE MOIETYC96613F5AV1
Benzoic AcidACTIVE MOIETY8SKN0B0MIM1
Bryonia Alba RootACTIVE MOIETYT7J046YI2B1
CausticumACTIVE MOIETYDD5FO1WKFU1
Cinchona Officinalis BarkACTIVE MOIETYS003A158SB1
Colchicum Autumnale BulbACTIVE MOIETY993QHL78E61
Hypericum PerforatumACTIVE MOIETYXK4IUX8MNB1
Iodide IonACTIVE MOIETY09G4I6V86Q1
Iris Versicolor RootACTIVE MOIETYX43D4L3DQC1
Ledum Palustre TwigACTIVE MOIETY877L01IZ0P1
Lithium CationACTIVE MOIETY8H8Z5UER661
Phytolacca Americana RootACTIVE MOIETY11E6VI8VEG1
Pseudognaphalium ObtusifoliumACTIVE MOIETY36XQ854NWW1
Ruta Graveolens Flowering TopACTIVE MOIETYN94C2U587S1
Sambucus Nigra Flowering TopACTIVE MOIETYCT03BSA18U1
StrychnineACTIVE MOIETYH9Y79VD43J1
Strychnos Nux-vomica SeedACTIVE MOIETY269XH139191
Toxicodendron Pubescens LeafACTIVE MOIETY6IO182RP7A1
Urtica UrensACTIVE MOIETYIHN2NQ5OF91
SucroseINACTIVE INGREDIENTC151H8M5541

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55714-229755714-2297-1, 55714-2297-2, 55714-2297-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SucroseSUCROSEC151H8M554ELIXIR / ORAL18000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, EMULSION / INTRAVENOUS970 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL18790 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TROCHE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS9.4 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SOLUTION / ORAL70000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION/ DROPS / ORAL3750 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS1 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION / SUBCUTANEOUS47.75 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CONCENTRATE / ORAL4800 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS900 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION, EXTENDED RELEASE / ORAL5400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION / INTRAVENOUS1950 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LIQUID / ORAL37500 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LOZENGE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554PASTILLE / ORAL426 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SYRUP / ORAL46400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SOLUTION / RECTAL35.42 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, DELAYED RELEASE / ORAL295.33 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS308 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, FILM COATED / ORAL145 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / BUCCAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTABLE, LIPOSOMAL / INTRAVENOUS7560 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER / ORAL27768 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUPPOSITORY / RECTALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, DELAYED RELEASE / ORAL955 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, EXTENDED RELEASE / ORAL619 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS2000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / ORAL4249 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE / ORAL3568 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LOZENGE / TRANSMUCOSAL1255 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, FILM COATED, EXTENDED RELEASE / ORAL119.12 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SOLUTION / ORAL42596 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TROCHE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SUSPENSION / ORAL31885 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER, FOR SUSPENSION / ORAL40017 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, COATED PELLETS / ORAL59.8 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554WAFER / ORAL155.2 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER, FOR SOLUTION / ORAL38666 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, COATED, EXTENDED RELEASE / ORAL86 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, CHEWABLE / ORAL7258 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION / ORAL48209 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, EXTENDED RELEASE / ORAL284.54 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / SUBLINGUAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, COATED / ORAL516.42 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554DROPS / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a73d4136-fab5-4280-8141-4eb9c02a347d7d643143-7305-bf15-cdeb-d0a6dffc1ba52011-03-01WarningsExact identifier
spl id: a73d4136-fab5-4280-8141-4eb9c02a347d
spl set id: 7d643143-7305-bf15-cdeb-d0a6dffc1ba5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.